Ezetimibe/simvastatin or atorvastatin for the treatment of hypercholesterolemia in patients with the metabolic syndrome: the VYMET study
- PMID: 20425579
- DOI: 10.1007/s11892-010-0107-5
Ezetimibe/simvastatin or atorvastatin for the treatment of hypercholesterolemia in patients with the metabolic syndrome: the VYMET study
Comment on
-
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).Am J Cardiol. 2009 Jun 15;103(12):1694-702. doi: 10.1016/j.amjcard.2009.05.003. Am J Cardiol. 2009. PMID: 19539078 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
